Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may lead to hyperacetylation of histones associated with the DYX1C1 gene promoter, resulting in a more open chromatin state that could decrease transcription of the DYX1C1 gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could inhibit DNA methylation at the DYX1C1 gene locus, potentially leading to a reduction in gene silencing and a subsequent decrease in DYX1C1 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid may induce hyperacetylation of histones near the DYX1C1 gene, which could hinder the recruitment of transcriptional repressors, resulting in a lowered expression of DYX1C1. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, as a histone deacetylase inhibitor, could promote an open chromatin configuration at the DYX1C1 locus, which could lead to a suppressed transcriptional activity of the DYX1C1 gene. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may cause increased acetylation of histones at the DYX1C1 promoter, potentially disrupting the initiation of transcription and leading to decreased levels of DYX1C1 mRNA. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A has the potential to bind DNA at the DYX1C1 gene promoter, obstructing transcription factor access and thus downregulating DYX1C1 gene transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may intercalate into DNA of the DYX1C1 gene, blocking RNA polymerase movement and leading to a reduction in the transcription of the DYX1C1 gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could inhibit the mTOR pathway, which may lead to reduced protein synthesis and could have downstream effects that result in the inhibition of DYX1C1 gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine may decrease DNA methylation levels at the DYX1C1 gene, which could lead to a reduction in the expression of the DYX1C1 gene by altering epigenetic marks that control gene silencing. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea can disrupt the DNA replication machinery, and this disruption could extend to a decrease in the transcriptional activity of genes such as DYX1C1. | ||||||